Artwork

内容由Darshan Kulkarni提供。所有播客内容(包括剧集、图形和播客描述)均由 Darshan Kulkarni 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

5 Common Clinical Trial Site Failures

1:07
 
分享
 

Manage episode 457646172 series 3506216
内容由Darshan Kulkarni提供。所有播客内容(包括剧集、图形和播客描述)均由 Darshan Kulkarni 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

Darshan discusses the five most common clinical trial site issues:

1. Failure to Follow Investigational Plan: Treating clinical trials like routine medical practice instead of strictly following the protocol can lead to serious issues.

2. Inadequate and Inaccurate Records: The FDA emphasizes that if it’s not documented, it didn’t happen. Inaccurate records can lead to compliance problems.

3. Inadequate Drug Accountability: Not knowing where your investigational product has gone is a major issue. The FDA expects thorough tracking and accountability.

4. Failure to Obtain and Document Subject Consent: Consent issues are a big problem, with 9% of clinical trial issues related to improper or insufficient documentation of consent.

5. Inadequate Subject Consent: Obtaining consent is critical, and inadequate consent is a common and problematic issue.

For help with clinical trial compliance, contact Darshan.


Support the show

  continue reading

190集单集

Artwork
icon分享
 
Manage episode 457646172 series 3506216
内容由Darshan Kulkarni提供。所有播客内容(包括剧集、图形和播客描述)均由 Darshan Kulkarni 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

Darshan discusses the five most common clinical trial site issues:

1. Failure to Follow Investigational Plan: Treating clinical trials like routine medical practice instead of strictly following the protocol can lead to serious issues.

2. Inadequate and Inaccurate Records: The FDA emphasizes that if it’s not documented, it didn’t happen. Inaccurate records can lead to compliance problems.

3. Inadequate Drug Accountability: Not knowing where your investigational product has gone is a major issue. The FDA expects thorough tracking and accountability.

4. Failure to Obtain and Document Subject Consent: Consent issues are a big problem, with 9% of clinical trial issues related to improper or insufficient documentation of consent.

5. Inadequate Subject Consent: Obtaining consent is critical, and inadequate consent is a common and problematic issue.

For help with clinical trial compliance, contact Darshan.


Support the show

  continue reading

190集单集

모든 에피소드

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南

边探索边听这个节目
播放